JP2011518787A - 痙直及び振戦のような術後作用をクロニジンで治療する方法 - Google Patents

痙直及び振戦のような術後作用をクロニジンで治療する方法 Download PDF

Info

Publication number
JP2011518787A
JP2011518787A JP2011505218A JP2011505218A JP2011518787A JP 2011518787 A JP2011518787 A JP 2011518787A JP 2011505218 A JP2011505218 A JP 2011505218A JP 2011505218 A JP2011505218 A JP 2011505218A JP 2011518787 A JP2011518787 A JP 2011518787A
Authority
JP
Japan
Prior art keywords
clonidine
drug depot
depot
muscle
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011505218A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518787A5 (https=
Inventor
キング，ヴァンジャ・マルガリータ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Publication of JP2011518787A publication Critical patent/JP2011518787A/ja
Publication of JP2011518787A5 publication Critical patent/JP2011518787A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2011505218A 2008-04-18 2009-04-17 痙直及び振戦のような術後作用をクロニジンで治療する方法 Pending JP2011518787A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4619208P 2008-04-18 2008-04-18
US61/046,192 2008-04-18
US12/408,491 US20090263443A1 (en) 2008-04-18 2009-03-20 Methods for treating post-operative effects such as spasticity and shivering with clondine
US12/408,491 2009-03-20
PCT/US2009/040885 WO2009129428A2 (en) 2008-04-18 2009-04-17 Methods for treating post-operative effects such as spasticity and shivering with clonidine

Publications (2)

Publication Number Publication Date
JP2011518787A true JP2011518787A (ja) 2011-06-30
JP2011518787A5 JP2011518787A5 (https=) 2012-01-19

Family

ID=41199746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011505218A Pending JP2011518787A (ja) 2008-04-18 2009-04-17 痙直及び振戦のような術後作用をクロニジンで治療する方法

Country Status (5)

Country Link
US (1) US20090263443A1 (https=)
EP (1) EP2207545B1 (https=)
JP (1) JP2011518787A (https=)
CN (1) CN101827592A (https=)
WO (1) WO2009129428A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021167331A (ja) * 2015-09-21 2021-10-21 テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーTeva Pharmaceuticals International GmbH 徐放性オランザピン製剤
US11813359B2 (en) 2017-03-20 2023-11-14 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulations

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
WO2012075447A2 (en) * 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
WO2012075451A2 (en) 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Clonidine and gaba compounds in a biodegradable polymer carrier
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
WO2019071245A1 (en) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. IMPLANTABLE DEPOSITS FOR REGULATED RELEASE OF ANALGESICS TO TREAT POSTHOPERATIVE PAIN ASSOCIATED WITH ORTHOPEDIC SURGERY, AND RELATED DEVICES, SYSTEMS, AND METHODS
WO2019136490A1 (en) 2018-01-08 2019-07-11 Foundry Therapeutics, Inc. Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents
EP3793536A1 (en) 2018-05-12 2021-03-24 Foundry Therapeutics, Inc. Implantable polymer depots for the controlled release of therapeutic agents
US12303619B2 (en) 2018-08-28 2025-05-20 Foundry Therapeutics, Inc. Polymer implants

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005538952A (ja) * 2002-05-21 2005-12-22 アラーガン、インコーポレイテッド 痛みを緩和するための新規な方法および組成物
WO2006011915A1 (en) * 2004-06-30 2006-02-02 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
NZ311474A (en) * 1995-06-09 1997-09-22 Euro Celtique Sa Formulations for providing prolonged local anesthesia
US6113624A (en) * 1995-10-02 2000-09-05 Ethicon, Inc. Absorbable elastomeric polymer
ATE203157T1 (de) * 1996-12-20 2001-08-15 Alza Corp Injizierbare depotgelzubereitung und herstellungsverfahren
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy
AU733868B2 (en) * 1998-05-12 2001-05-31 Boston Scientific Limited Manual bone anchor placement devices
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6927044B2 (en) * 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US6436099B1 (en) * 1999-04-23 2002-08-20 Sdgi Holdings, Inc. Adjustable spinal tether
US7220281B2 (en) * 1999-08-18 2007-05-22 Intrinsic Therapeutics, Inc. Implant for reinforcing and annulus fibrosis
US7329529B2 (en) * 1999-09-03 2008-02-12 Millennium Pharmaceuticals, Inc. Ubiqutin proteases
US7951201B2 (en) * 1999-10-20 2011-05-31 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
AU774481B2 (en) * 1999-12-06 2004-07-01 Warsaw Orthopedic, Inc. Intervertebral disc treatment devices and methods
US6589549B2 (en) * 2000-04-27 2003-07-08 Macromed, Incorporated Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
ES2320533T3 (es) * 2001-01-03 2009-05-25 BAUSCH & LOMB INCORPORATED Dispositivos de administracion de farmacos de liberacion sostenida con multiples agentes.
US7229441B2 (en) * 2001-02-28 2007-06-12 Warsaw Orthopedic, Inc. Flexible systems for spinal stabilization and fixation
AU2002254157B2 (en) * 2001-03-09 2006-07-27 Boston Scientific Limited Medical slings
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
US6974462B2 (en) * 2001-12-19 2005-12-13 Boston Scientific Scimed, Inc. Surgical anchor implantation device
US8133501B2 (en) * 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US20040109893A1 (en) * 2002-06-25 2004-06-10 Guohua Chen Sustained release dosage forms of anesthetics for pain management
AU2003249317B2 (en) * 2002-07-19 2007-08-02 Institute Of Materials Research And Engineering Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from
US20040166088A1 (en) * 2003-01-15 2004-08-26 Shalaby Shalaby W. Polymeric precursors of non-absorbable, in situ-forming hydrogels and applications thereof
MXPA05013003A (es) * 2003-05-30 2006-03-17 Alza Corp Composiciones de deposito elastomerico implantables, usos de las mismas y metodo para elaboracion.
US7144412B2 (en) * 2003-06-25 2006-12-05 Wolf Medical Enterprises, Inc. Gold suture and method of use in wound closure
US20050059744A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
US20050148512A1 (en) * 2003-11-10 2005-07-07 Angiotech International Ag Medical implants and fibrosis-inducing agents
US20050175709A1 (en) * 2003-12-11 2005-08-11 Baty Ace M.Iii Therapeutic microparticles
CA2536096A1 (en) * 2004-01-30 2005-08-18 Angiotech International Ag Compositions and methods for treating contracture
US7361168B2 (en) * 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US7410480B2 (en) * 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8512730B2 (en) * 2004-07-12 2013-08-20 Isto Technologies, Inc. Methods of tissue repair and compositions therefor
US20060046961A1 (en) * 2004-09-02 2006-03-02 Mckay William F Controlled and directed local delivery of anti-inflammatory compositions
US20060074422A1 (en) * 2004-09-27 2006-04-06 Story Brooks J Suture anchor and void filler combination
US20060253100A1 (en) * 2004-10-22 2006-11-09 Medtronic, Inc. Systems and Methods to Treat Pain Locally
EA200701131A1 (ru) * 2004-11-24 2007-12-28 Алгоркс Фармасьютикалз, Инк. Гелеобразная препаративная форма капсаициноида и способы её применения
US7611494B2 (en) * 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
US20060183786A1 (en) * 2005-02-16 2006-08-17 Chi Mei Foundation Hospital Injectable long-acting analgesic composition comprising an ester derivative of ketorolac
US20070248639A1 (en) * 2005-05-20 2007-10-25 Omeros Corporation Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
US7610100B2 (en) * 2005-12-30 2009-10-27 Boston Scientific Neuromodulation Corporation Methods and systems for treating osteoarthritis
US7741273B2 (en) * 2006-04-13 2010-06-22 Warsaw Orthopedic, Inc. Drug depot implant designs
US20070253994A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain
WO2008003093A2 (en) * 2006-06-29 2008-01-03 Questcor Pharmaceuticals, Inc. Pharmaceutical compositions and related methods of treatment
CA2697784A1 (en) * 2006-07-07 2008-01-10 Bioassets Development Corporation Novel regimens for treating diseases and disorders
US20080091207A1 (en) * 2006-10-13 2008-04-17 Csaba Truckai Bone treatment systems and methods

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005538952A (ja) * 2002-05-21 2005-12-22 アラーガン、インコーポレイテッド 痛みを緩和するための新規な方法および組成物
WO2006011915A1 (en) * 2004-06-30 2006-02-02 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6013026468; ＡＮＥＳＴＨ．　ＡＮＡＬＧ． ＶＯＬ．９９, 2004, Ｐ．７１８-７２７ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021167331A (ja) * 2015-09-21 2021-10-21 テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーTeva Pharmaceuticals International GmbH 徐放性オランザピン製剤
US11813359B2 (en) 2017-03-20 2023-11-14 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulations

Also Published As

Publication number Publication date
EP2207545B1 (en) 2016-01-06
EP2207545A4 (en) 2012-02-15
CN101827592A (zh) 2010-09-08
WO2009129428A3 (en) 2009-12-23
WO2009129428A2 (en) 2009-10-22
US20090263443A1 (en) 2009-10-22
EP2207545A2 (en) 2010-07-21

Similar Documents

Publication Publication Date Title
JP5341172B2 (ja) 生分解性ポリマー担体中のクロニジン製剤
US9265733B2 (en) Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
JP5893061B2 (ja) 疼痛および／または炎症の治療のためのαアドレナリン作動性受容体アゴニスト
US8980317B2 (en) Methods and compositions for treating infections comprising a local anesthetic
JP2011518787A (ja) 痙直及び振戦のような術後作用をクロニジンで治療する方法
JP2011518167A (ja) クロニジンおよびブピバカインを用いて術後疼痛を処置するための組成物および方法
JP2011518183A (ja) 液体製剤と組み合わせて製剤化した薬物デポー剤で急性疼痛を治療するための方法
JP2011508789A (ja) 変性円板疾患の治療のためのαアドレナリン作動性受容体アゴニスト
US20130261095A1 (en) Dexamethasone Formulations in a Biodegradable Material
JP2011518187A (ja) 局所麻酔薬を含む術後疼痛を処置する方法および組成物
US20100203102A1 (en) Compositions and methods for treating post-operative pain using bupivacaine and an anti-onflammatory agent
JP2011518181A (ja) 炎症性疾患の治療のためのαアドレナリン作動性受容体アゴニスト
JP2011517699A (ja) 生分解性材料中のスリンダク製剤
JP2011508791A (ja) 生物分解性ポリマー担体中のフルオシノロン製剤
US20100228097A1 (en) Methods and compositions to diagnose pain
JP2011513337A (ja) 椎間板ヘルニアを治療するための方法および組成物
US20090264478A1 (en) Sulfasalazine formulations in a biodegradable polymer carrier
AU2015203047A1 (en) Method for treating acute pain with a formulated drug depot in combination with a liquid formulation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111124

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20111124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130902

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20131029